Altergon competitive analysis

Loading summary...

Explore Altergon's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 30, 2023Single-Dose Pharmaceutical Preparation Of Thyroid Hormones T3 And/Or T41
Jun 28, 2023Compositions Comprising Glycosaminoglycans Of Low Viscosity And Use Of Said Composition In Therapy Of Chronic Cystitis1
Jul 22, 2020High-Stability Packaged Solutions Of T4 Thyroid Hormone1

Latest publications and patents of Altergon New

Explore the latest publications and patents granted to Altergon, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Altergon

Aug 30, 2023Single-Dose Pharmaceutical Preparation Of Thyroid Hormones T3 And/Or T4Patent Maintained As Amended
Jun 28, 2023Compositions Comprising Glycosaminoglycans Of Low Viscosity And Use Of Said Composition In Therapy Of Chronic CystitisPatent Maintained As Amended
Jul 22, 2020High-Stability Packaged Solutions Of T4 Thyroid HormoneRevoked
Jan 3, 2018Aqueous Oral Solutions Of Steroid Hormones And Hydroxypropyl-Beta-Cyclodextrin With Optimised BioavailabilityNo Opposition Filed Within Time Limit

Latest PTAB cases involving Altergon

Discover the latest PTAB cases involving Altergon, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Altergon with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ALTERGON - 3 - -
STREHLKE3 - - -
UNI PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES2 - - -